</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →
3004.90.92.65/K-Dur 20 Extended-Release Tablets/Canada

K-Dur 20 Extended-Release Tablets from Canada

Extended-release potassium chloride tablets (20 mEq) designed for once-daily dosing to prevent potassium deficiency in patients with diuretic-induced hypokalemia. Classified under HTS 3004.90.92.65 due to its mixed formulation primarily affecting electrolytic balance, packaged in retail blister packs. The controlled-release matrix ensures steady electrolyte replenishment.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.05.860%Universal product exemption (U.S. note 52(b))
Calculate with your customs valueVerify classification with AI

Import Tips

• Include FDA registration and drug listing numbers; ensure NDC coding on packaging for seamless CBP clearance

• Document bioequivalence to US reference standards to prevent delays in therapeutic equivalence verification

• Avoid common error of insufficient stability data, critical for extended-release formulations during import inspection

K-Dur 20 Extended-Release Tablets from Canada — Import Duty Rate | HTS 3004.90.92.65